Why don't BBs do RX?
From what I understand, their size and balance sheet typically presents a conflict of interest due to who owns debt, but I'm having some trouble fully understanding and would really appreciate an explanation.
From what I understand, their size and balance sheet typically presents a conflict of interest due to who owns debt, but I'm having some trouble fully understanding and would really appreciate an explanation.
+128 | If Tik Tok is forced to sell, what banks do you think would be involved in the deal? | 59 | 1d | |
+49 | Intern Ettiquette | 14 | 3h | |
+44 | Ranking banks that went under | 34 | 1h | |
+39 | Burnt Out M&A ASO | 22 | 23h | |
+38 | Relevance of A-Levels for U.K. London recruiting | 27 | 24s | |
+26 | What are hours like at BBs in London? | 48 | 10h | |
+26 | 2024 new grads who didnt get return offers update | 12 | 10h | |
+19 | 3.7 at semi target, how can I prep for recrutiing | 5 | 4d | |
+19 | Lateral from BB M&A to MM A&D - Tips for Interviewing for A&D? | 7 | 4d | |
+19 | PSA to gymcels: focus on the summer internship | 9 | 1d |
Career Resources
Because RX is for NERDS and we are BB CHADS
Imagine BB originates bank loan tranche to CrapCo.
CrapCo is in finance stress. Are they going to retain the BB as a debtor-focuses RX group? Obviously not, cause the bank isn’t about to negotiate against itself to cut its own exposure and take a loss. Similar, are the holders of other tranches going to retain the bank as a creditor-focuses RX group? Obviously not, cause the bank isn’t about to argue to allocate value away from the bank loan tranche.
Maybe when private debt funds complete overtake leveraged loan issuers we will see BB RX groups (being somewhat sarcastic)
Thanks. I understand now.
RX is a somewhat esoteric skillset and building it out at a bank would require a huge amount of time and money invested. RX groups also don't generate the same level of fees as BB coverage groups which get both M&A and financing fees. BBs' strengths are their balance sheets which they can't monetize in RX processes outside of providing DIP financing, which they already have desks that do that, and even in that case there would be an inherent conflict between an RX advisor and a DIP financing desk. So there really isn't a huge incentive for them to do so, and notable conflicts. It's just not something that really lends itself to BBs.
Because it’s a conflict of interest.
GS has an RX team
Iste totam occaecati et hic consequatur earum. Omnis eveniet quisquam accusantium ipsum consectetur quis. Est aperiam ea explicabo omnis qui maiores repellendus maiores. In odio impedit minus magnam ea.
Fugit maxime quod suscipit quae repudiandae optio. Suscipit tenetur nisi et error corporis non recusandae. Tempora temporibus facilis rerum possimus voluptas.
Perspiciatis fugit tempora alias et. Distinctio recusandae autem veniam est. Possimus architecto saepe sint cupiditate voluptate.
Maxime eum iste quia fugit corporis ea modi. Repudiandae provident sit ab officia sed suscipit. Dolorem eum voluptatum labore dolor nobis maxime.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...